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Abstract: The motor thalamus (MTh) plays a crucial role in the basal ganglia (BG)-cortical loop
in motor information codification. Despite this, there is limited evidence of MTh functionality
in normal and Parkinsonian conditions. To shed light on the functional properties of the MTh,
we examined the effects of acute and chronic dopamine (DA) depletion on the neuronal firing of
MTh neurons, cortical/MTh interplay and MTh extracellular concentrations of glutamate (GLU) and
gamma-aminobutyric acid (GABA) in two states of DA depletion: acute depletion induced by the
tetrodotoxin (TTX) and chronic denervation obtained by 6-hydroxydopamine (6-OHDA), both infused
into the medial forebrain bundle (MFB) in anesthetized rats. The acute TTX DA depletion caused a
clear-cut reduction in MTh neuronal activity without changes in burst content, whereas the chronic
6-OHDA depletion did not modify the firing rate but increased the burst firing. The phase correlation
analysis underscored that the 6-OHDA chronic DA depletion affected the MTh-cortical activity
coupling compared to the acute TTX-induced DA depletion state. The TTX acute DA depletion
caused a clear-cut increase of the MTh GABA concentration and no change of GLU levels. On the
other hand, the 6-OHDA-induced chronic DA depletion led to a significant reduction of local GABA
and an increase of GLU levels in the MTh. These data show that MTh is affected by DA depletion
and support the hypothesis that a rebalancing of MTh in the chronic condition counterbalances the
profound alteration arising after acute DA depletion state.
Keywords: electrophysiology; microdialysis; immunohistochemistry; L-DOPA; deep brain
stimulation
1. Introduction
The motor thalamus (MTh) plays a pivotal role in motor information processing in both physiological
and pathological conditions, being directly connected to both the basal ganglia (BG) and the cortex [1]. In
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particular, the MTh receives the BG input at the level of the ventral-anterior (VA) and the ventral-medial
(VM) nuclei [2]. BG are assumed to inhibit the thalamus under basal conditions because substantia nigra
pars reticulata (SNr) and internal globus pallidus (GPi) display high spontaneous spiking rates, releasing
GABA in the MTh. However, when the BG network is activated by cortical input, BG output is transiently
suppressed and downstream targets, including the MTh, are disinhibited [3,4]. Another source of
GABA in the MTh comes from the nucleus reticular thalami (NRT) [5], a thin layer of GABAergic cells
adjacent to the relay nuclei of the dorsal thalamus, that we have shown to be able to modulate the
oscillatory activity of MTh in dopamine (DA)-depleted animals [6]. On the other hand, the excitatory
input to the MTh is classically provided by the cerebellothalamic [7] and corticothalamic synapses [8,9].
Moreover, it has been recently shown that some substantia nigra (SN) neurons project to the NRT and
the posterior thalamus, and co-release glutamate (GLU) and DA, while the VA and VM would receive
preferential GABAergic SN fibers [10]. GABA, GLU and DA, therefore, may interact when modulating
synapse and excitability within the MTh in normal and pathological conditions [11–14]. Although it is
well established that the appearance of the cardinal features of Parkinson’s disease (PD) is due to the
degeneration of DA neurons, with the contextual dysfunction of different neurotransmitter systems and
cortical and BG activity [15–17], the evidence of MTh alterations, both at the circuit and cellular level, is
scanty and controversial [1,6]. According to the canonical BG schema [18,19], an increase in MTh GABA
levels could be the consequence of the DA loss. This agrees with clinical evidence showing that clinical
effective sub-thalamic nucleus (STN) deep brain stimulation (DBS) or even levodopa (L-DOPA) in PD
patients reversibly reduced the extracellular MTh GABA [20,21]. Nevertheless, a decrease of GABA
has been observed in the MTh of 6-OHDA-lesioned rats [22] and certain regions of the thalamus of
post-mortem PD brains [23]. Therefore, these discrepancies cannot be only due to the difference in BG
circuitry in rats compared to humans.
No changes in GLU concentrations have been described in the thalamuses of PD patients [23],
or the striatum or SNr of 6-OHDA-lesioned rats [24]; there was a GLU increase in the entopeduncular
nucleus (EPN) [25], in the SNr and the striatum in L-DOPA-induced dyskinesia (LID) 6-OHDA rat [24].
Indeed, AMPA, NMDA and metabotropic GLU receptor antagonists might be a useful target for PD,
especially for LID (Cenci et al., 2014).
Finally, the role of the MTh in PD is questioned by the fact that a stereotactic MTh lesion neither
worsens Parkinsonian bradykinesia in PD nor regularly causes bradykinesia in patients with essential
tremor [26], clearly in contrast to the canonical box and arrow schema of BG [18,19].
Thus, the present study was aimed at elucidating the effects of acute and chronic DA depletion,
induced respectively by TTX and 6-OHDA [27], on MTh functionality. We, therefore, investigated
the electrophysiological changes in the MTh at the level of single neurons from acute and chronic
DA-depleted rats. Our main hypothesis was that the MTh is altered differently during rapid changes
of DA levels compared to chronic depleted states. This might account for the controversial findings
on MTh. Since the BG activity changes in relation to the cortical pattern [28,29], all the recordings
were performed during stable cortical slow-wave activity (SWA) induced by urethane anesthesia. This
stable cortical pattern allowed us to investigate the coupling of SWA activity with the MTh neuronal
activity in acute and chronic DA depletion states. In addition, we measured the extracellular levels of
GABA and GLU by microdialysis in the same experimental conditions.
2. Results
2.1. Effects of DA Depletion on the Activity of the Motor Thalamus Neurons
We recorded a total of 82 neurons from the MTh (n = 23 control, n = 25 in 6-OHDA and n = 34 in
TTX, Figure 1). We found that the mean firing rate of the recorded MTh neurons was lower after TTX
infusion (TTX: 3.69 ± 0.18 spike/s, p < 0.05) compared to control group (CTL: 7.12 ± 0.15 spikes/s) and
6-OHDA-lesioned rats (6-OHDA: 8.02 ± 0.29 spikes/s; p < 0.05) (Figure 2a). The percentage of spikes
in burst in chronic 6-OHDA DA-depleted rats (6-OHDA 76.72 ± 4.18%) was higher than in control
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(CTL 59.89 ± 4.22%, p < 0.05) and TTX groups (60.53 ± 6.30%, p < 0.01) (Figure 2b). Burst length and
interspike of burst (Figure 2c,d) were significantly higher in chronic than in acute TTX-mediated DA
depletion but were not different from controls (length of burst: 6-OHDA 34.03 ± 3.01 ms, TTX 22.84 ±
2.61 ms, p < 0.05; burst interspike: 6-OHDA 15.33 ± 1.65 ms, TTX 10.5 ± 1.29 ms).
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MTh recording site in tetrodotoxin (TTX)-treated rats (in blue). The black circles represent the recorded
neurons in MTh during the TTX-mediated blockade of MFB.
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MTh (blue) in control (dark color), acute (dashed color) and chronic (light color) DA depletion states.
On the left, the representation of hypothetical cortical slow oscillation comparing the phase angle and
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vector length between MTh (blue) control (dark color), TTX (dashed color) and 6-OHDA (light color)
rats. * p < 0.05, Kruskal–Wallis test. MTh: motor thalamus; CTL: control; TTX: tetrodotoxin; 6-OHDA:
6-hydroxydopamine. The 0◦ represents the mid-ascending phase of cortical slow-wave activity
(SWA), the 90◦ represents the cortical SWA peak and the 180◦ represents the mid-descending phase of
cortical SWA.
2.2. Effects of DA Depletion on the Cortical–Thalamic Coupling
We compared the preferred phase angles and the vector lengths in control, acute and chronic
DA depletion states. In control rats, the MTh neurons fired preferentially at 42.77 ± 12.36◦ (n = 21,
Figure 2e), with a vector length of 0.73 ± 0.06. In acute DA-depleted animals (n = 34), the phase was
22.54 ± 6.96◦ with a vector length of 0.83 ± 0.03, while in the chronic DA depletion state (n = 22), it was
79.89 ± 15.98◦ with a vector length of 0.56 ± 0.07. The vector length, i.e., the strength of corticothalamic
coupling, was significantly lower in chronic DA depletion state than in control and in acute DA
depletion state (p < 0.05). The phase angle was significantly lower in control and acute DA depletion
state than that in chronic DA depletion state (p < 0.05) (Figure 2e).
2.3. Effects of DA Depletion on the Extracellular Levels of GABA and GLU in the Motor Thalamus
ANOVA analysis followed by Dunnet’s multiple comparison test showed a significant effect of
TTX infused in the medial forebrain bundle induced an increase in the endogenous GABA extracellular
level (215 ± 67.5; n = 14; p < 0.05) compared to the control (100 ± 7.90, n = 14) and post-infusion
period (159.2 ± 50.2, n = 14) (Figure 3a). No changes in the GLU levels were observed in the MTh
after the infusion of TTX (PRE: 100 ± 2.69; TTX: 122.7 ± 24.8, n = 7; POST: 123.7 ± 53.9, n = 14)
(Figure 3b). The extracellular GABA levels in the MTh were significantly lower in 6-OHDA animals
than in sham-lesioned animals (100 ± 11.09 vs. 43.54 ± 6.65, n = 9; ** p < 0.01) (Figure 3c). GLU
levels were significantly augmented in the MTh of 6-OHDA rats when compared to those measured
in sham-lesioned rats by unpaired student t-test (100 ± 13.75 vs. 276.69 ± 43.52, n = 9; ** p < 0.01)
(Figure 3d) levels.
Int. J. Mol. Sci. 2020, 21, 2734 5 of 13
Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 5 of 13 
 
 
Figure 3. Effect of acute (TTX) and chronic (6-OHDA) dopamine (DA)-depletion on the extracellular 
levels of endogenous GABA and glutamate (GLU) in the motor thalamus (MTh). TTX infused in the 
medial forebrain bundle induced an increase in the endogenous GABA extracellular levels (A) while 
did not change the GLU levels in the MTh. Data in (A) and (B) are expressed as mean ± SEM 
normalized to the baseline levels (pre TTX infusion) from n = 14 experiments per group; * p < 0.05. 
One-and two-way ANOVA for repeated measures, followed by Dunnet’s multiple comparison test. 
6-OHDA-lesion infused in the medial forebrain bundle produced, after 2 weeks, a decrease in GABA 
(C) and an increase in GLU extracellular levels in the MTh (D). Data in (C) and (D) are expressed as 
means ± SEMs normalized to sham-lesioned (n = 9) neurotransmitter levels from n = 9 experiments 
per group; ** p < 0.01, unpaired student t-test. 
3. Discussion 
We demonstrated that MTh is deeply affected by both acute and chronic DA depletion both in 
terms of electrophysiological and neurochemical alterations. The main findings of the present study 
are threefold. Firstly, the results emphasize the different effects of DA deafferentation on MTh, with 
a decrease in firing rate in TTX-treated animals and an increase of burst firing in 6-OHDA-lesioned 
rats. Secondly, the results show that DA depletions change, in an opposite fashion, MTh-cortical 
coupling with the MTh neurons fired preferentially at the beginning of the UP-state in TTX-treated 
rats compared to the 6-OHDA-lesioned rats, which showed a shift towards the peak of the SWA. 
Finally, the neurochemical results demonstrated that the extracellular levels of GABA increase and 
those of GLU do not change in the MTh of TTX-treated animals; in the 6-OHDA-lesioned rats, GABA 
levels decreased and those of GLU increased. 
Figure 3. Effect of acute (TTX) and chronic (6-OHDA) dopamine (DA)-depletion on the extracellular
levels of endogenous GABA and glutamate (GLU) in the motor thalamus (MTh). TTX infused in
the medial forebrain bundle induced an increase in the endogenous GABA extracellular levels (A)
while did not change the GLU levels in the MTh. Data in (A) and (B) are expressed as mean ± SEM
normalized to the baseline levels (pre TTX infusion) from n = 14 experiments per group; * p < 0.05.
One-and two-way ANOVA for repeated measures, followed by Dunnet’s multiple comparison test.
6-OHDA-lesion infused in the medial forebrain bundle produced, after 2 weeks, a decrease in GABA
(C) and an increase in GLU extracellular levels in the MTh (D). Data in (C) and (D) are expressed as
means ± SEMs normalized to sham-lesioned (n = 9) neurotransmitter levels from n = 9 experiments per
group; ** p < 0.01, unpaired student t-test.
3. Di cussion
We demonstrated that MTh is deeply affected by both acute and chronic DA depletion both in
terms of electrophysiological and neurochemical alterations. The main findings of the present study
are threefold. Firstly, the results emphasize the different effects of DA deafferentation on MTh, with
a decrease in firing rate in TTX-treated animals and an increase of burst firing in 6-OHDA-lesioned
rats. Secondly, the results show that DA depletions change, in an opposite fashion, MTh-cortical
coupling with the MTh neurons fired preferentially at the beginning of the UP-state in TTX-treated rats
compared to the 6-OHDA-lesioned rats, which showed a shift towards the peak of the SWA. Finally,
the neurochemical results demonstrated that the extracellular levels of GABA increase and those of
GLU do not change in the MTh of TTX-treated animals; in the 6-OHDA-lesioned rats, GABA levels
decreased and those of GLU increased.
Despite representing a crucial point in the cortico-BG circuit, only a few studies have investigated
the role of the MTh and its properties in PD, and controversial data are present in the literature [1,6].
Furthermore, controversial data are present in the literature which regard MTh electrophysiology and
properties in the Parkinsonian state. While some studies show a slight MTh firing rate reduction in
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awake Parkinsonian monkeys [30–34], others revealed increased [1] or unchanged firing rates [35]. We
recently showed that all the EEG frequency bands are altered in TTX and 6-OHDA-depleted states;
MTh oscillation changes occur preferentially in acute DA depletion, but not in the chronic state [6].
In the present study, we demonstrated that the TTX-inhibition of the medial forebrain bundle
(MFB) (for technical details, see our review [27]) determined an acute increase in GABA content with
the reduction of the MTh activity. In rats, the SNr activity is reduced after acute DA depletion caused
by TTX [36], in accordance with electrophysiological and biochemical data obtained in PD patients [37].
Thus, the changes in MTh activity have to be due to other GABAergic afferents of the network. For
instance, we occasionally recorded NRT neurons during TTX infusion and observed a consistent
increment of their activity (unpublished observation). Considering that NRT is a powerful modulator
of different high-order thalamic nuclei [38], it is likely that this nucleus tightly controls the MTh as
well. Conversely, we observed that the MTh neuronal firing rate returns to control condition in the
chronic depletion state induced by 6-OHDA. This could be due to the aberrant decrease in GABA and
an increase in GLU levels in the MTh of 6-OHDA-lesioned rats that might compensate for the marked
inhibition observed in the acute depletion state. The shift of the excitation/inhibition (E/I) balance
toward a net excitation in the MTh of the 6-OHDA lesioned rats might indicate that the plastic changes
observed in the striatum and cortex of the PD animal model [39] could also occur at the level of the
thalamic area. Surprisingly, GABA levels decrease in the chronic DA-depleted MTh, a finding that
cannot be explained by the canonical BG/thalamus/cortex loop [19]. Nevertheless, our data, although
surprising, are in line with the findings of the only available in vivo study showing a decrease of GABA
in the MTh of rats lesioned by striatal infusion of 6-OHDA [22]. Instead, we are the first to report
a sustained GLU increase in the MTh of animal models of PD. The decrease in GABA levels is not
trivial since the administration of the vasoactive intestinal peptide (VIP) was effective at reversing the
motor deficits and contextually increased thalamic GABA contents [22]. Other areas may be involved
in rebalancing the MTh activity in chronic DA depletion, such as hyperactivity of the cortex, likely
leading the increased release of GLU that we observed within the MTh of 6-OHDA-lesioned rats. The
increase of burst activity in the MTh that we recorded in 6-OHDA conditions might depend on the
cortex, which, by acting as the main driver, produces a burst input, leading to a coincident burst of
activity in MTh neurons, without necessarily causing LTS bursts [1]. The fact that we did not observe a
strong effect on burst activity may depend on the canceling effects of different inputs to the MTh, such
as synchronized bursts from the BG. The contextual increase in GLU may also cause the production of
nitric oxide and contribute to PD development processes [15,40,41].
However, it is also necessary to underline that, since the lesion in our study was unilateral,
we cannot exclude that the contralateral hemisphere could compensate, at least partially, for these
changes [42]. Furthermore, a recent tractography study in healthy subjects showed that MTh may
receive DAergic projections from the ventral tegmental area that are directed towards the supplementary
motor area and primary motor cortex (44).
An interesting finding of this study is the interplay between motor thalamus and cortical activity.
The DA depletion influenced mainly the MTh-cortical coupling. The divergence of MTh-SWA coupling
in the chronic state of DA depletion further suggests that the MTh has undergone the effect of
compensatory mechanisms, changing the cross-talk between MTh and the cortex. In accordance with
the SWA pattern, the MTh neurons fired preferentially at the beginning of the UP-state in TTX-treated
rats compared to the 6-OHDA-lesioned rats, which showed a shift towards the peak of the SWA.
Thus, in 6-OHDA rats, there is a delay in the coupling between neuronal activity and the beginning of
cortical SWA
We showed that, following the acute reduction of DA, the MTh immediately changes the activity,
but the chronic lack of DA leads other structures to rebalance the MTh activity. It is possible to
hypothesize that, inside the complex circuit involved in PD, rapid clinical transitions of the motor and
non-motor symptoms could be directly related to rapid changes in MTh activity, as observed during
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DBS surgery [20,21]. These hypotheses need further investigation of the MTh activity in PD animal
models and PD patients.
Our study presents a number of limitations. For instance, we should keep in mind that our
recordings and the position of the microdialysis probe were at ranges of depths in the MTh that
correspond to both basal ganglia and cerebellar recipient zones. Therefore, our electrophysiological
and neurochemical data may have included values obtained from the two different MTh territories.
Moreover, we did not distinguish the two types of MTh neurons during cortical activation by performing
the tail-pinch (Nakamura et al., Cerebral cortex, 2014). Further experiments will be required to identify
the tonic and burst firing cells in MTh in response to cortical activation, and the eventual changes of
their firing characteristics following DA depletion by TTX and 6-OHDA treatment. Another limitation
of this study is the use of toxin-induced PD animal models and anesthetized preparations. Despite the
usefulness of the animal models, they have limitations that need to be considered when interpreting
our findings and translating them to humans [27]. Nevertheless, although rodent models cannot
recapitulate all features of PD, they remain a crucial approximation in order to open new avenues.
In conclusion, our data show that in chronic conditions, the firing changes observed in the MTh
are relatively mild, considering the profound changes observed in other BG nuclei. This could be due
to remodeling and adaptation developed as a consequence of the DA depletion. Indeed, acute TTX
induced a strong decrease in the firing rate of MTh neurons. On the other hand, the modification of
GLU and GABA are highly significant in 6-OHDA DA-depleted rats and are likely a consequence
of changes in the MTh inputs, difficult to explain with the current knowledge of PD pathology. The
roles of the MTh in the mechanisms of information processing under physiological and pathological
conditions need to be further investigated and clarified.
4. Materials and Methods
4.1. Animals
Most of the electrophysiological, neurochemical and histological procedures were carried out on
adult male Sprague-Dawley rats in compliance with Swiss laws on animal experimentation, and all
procedures were approved by the Animal Research Committee and the Veterinary Office of the Canton
of Ticino, Switzerland (TI-08-2015).
A subset of neurochemical experiments was performed on male Sprague-Dawley rats at the
Department of Physiology and Biochemistry at the University of Malta in accordance with the European
Union (EU) Directive 2010/63/EU and the Institutional Animal Use and Care Committee (IAUCC) of
the University of Malta.
Utmost care was taken to limit the number of rats used and their suffering.
4.2. Pharmacological Blockade of the Medial Forebrain Bundle
The pharmacological blockade of the MFB was performed on adult male Sprague–Dawley rats
weighing 399 ± 68.4 g according to our previously described method [6,27]. Briefly, TTX was infused
via reverse microdialysis using a probe with a 1 mm dialytic membrane (CMA/11 microdialysis probe,
CMA Microdialysis, Stockholm, Sweden), which was positioned according to the following coordinates:
2.5 mm posterior to the bregma, 2 mm lateral to the midline and 8.6 mm below the cortical surface [43].
The probe was perfused with saline solution for 1 h and then with TTX (1 µM) using a syringe pump
(CMA/400, CMA Microdialysis) at a flow rate of 1 µL/min. The MTh neuronal activity was recorded
and analyzed for at least the next 10 min after the TTX infusion in 27 animals, while the GABA and
GLU MTh levels were measured in 14 rats.
4.3. Unilateral 6-OHDA Lesion
We performed standard unilateral 6-OHDA denervation in the left hemisphere [6,27] to obtain
chronic DA-depleted animals. The animals (399 ± 36.3 g) were anesthetized with 1.5%–2.5% isoflurane
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in oxygen and then injected with desipramine (25 mg/kg, i.p.) and pargyline (50 mg/kg, i.p.) to
minimize 6-OHDA uptake by noradrenergic neurons and metabolism by MAO, respectively. Then,
the animals were mounted on a stereotaxic instrument (Stoelting Co., Wheat Lane, Wood Dale, IL,
USA) for injection of the neurotoxin (6-OHDA; Sigma; 8 µg/4 µL of saline solution containing 0.1%
of ascorbic acid) in the medial forebrain bundle (MFB; stereotaxic coordinates: 2.5 mm posterior
to the bregma, 2 mm lateral to the midline, and 8.6 mm below the cortical surface) [44]. The MTh
neuronal activity was recorded an analyzed in 6-OHDA-lesioned rats (n = 8) and control animals
(n = 6). The microdialysis experiments were performed in sham animals (n = 9), receiving instead,
4 µL of saline solution containing 0.1% of ascorbic acid infused into the MFB and 6-OHDA-lesioned
animals (n = 9). Electrophysiological and microdialysis experiments were performed 21–29 days after
the administration of 6-OHDA
4.4. Prerecording Surgery
Rats were anesthetized with urethane (1.4 g/kg, i.p.) (Sigma Chemical Co., St Louis, MO,
USA) and mounted on a stereotaxic instrument (Stoelting Co.) according to our standard operating
procedure [6,27]. Body temperature was maintained at 37–38 ◦C with a heating pad (Stoelting Co.).
After a local anaesthetic injection (lidocaine 0.5%), a midline scalp incision was made, and the skull was
almost completely drilled on the left side. The dura were then spread out to expose the cortical surface.
4.5. Electrophysiological Recordings
We recorded single neurons for the entire dorsoventral track in the same medio-lateral site in the
MTh. In particular, we recorded a total of 82 neurons from the MTh (n = 23 control, n = 25 in 6-OHDA
and n = 34 in TTX) from 5000 µm from the cortex to a maximum of 5770 µm.
We recorded multiple MTh neurons from TTX infused rats over the 10 min after infusion The MTh
neurons (n = 34) recorded after the TTX-mediated blockade of the MFB were localized from 5250 µm to
5870 µm from the first neuronal detection of the cortex.
The MTh neurons recorded were localized at the following coordinates: 1.8 mm posterior and
2.2 medial to bregma. Single unit activity was off-line analyzed using Spike 2 software (Cambridge
Electronic Design, Cambridge, UK) and principal component analysis for spike sorting.
The Electrocorticogram (ECoG) was recorded through a screw electrode (Dentorama, 8 mm of
total length, 3 mm tip length) placed on the cortical surface above the frontal cortex (3.0 mm anterior
of bregma and 2.0 mm lateral to the midline) and referenced against an indifferent screw electrode
placed above the cerebellum. Raw ECoG was bandpass filtered (0.1–300 Hz) and amplified (×2000;
Neurolog). The ECoG was on-line digitalized at a sample rate of 600 kHz through an analogical/digital
interface (Micro1401 mk II, Cambridge Electronic Design, Cambridge, UK) and stored on a computer
to identify off-line robust SWA, which will be the object of further analysis. Simultaneously, we
collected the single-unit activity from the MTh. The acquisition of the recording was performed after
the stabilization of neuronal activity. The recordings were performed using a tungsten electrode (WPI,
TM33B01; impedance 0.9–1.2 MΩ). The trace containing the neuron action potentials was amplified
(×10,000; Neurolog), bandpass filtered (300–1000 Hz) and sampled at 60 kHz for digital storage on a
computer connected to the CED 1401 interface [36]. The neuronal activity was recorded for at least
10 min after the TTX infusion.
Figure 1A shows an example of the recordings with the EEG traces, i.e., SWA (top panel); the
discriminated single neurons (middle panel); and the neuronal traces (bottom panel).
4.6. Microdialysis Analysis
An additional series of experiments were conducted on adult rats (312 ± 25 g) to measure
GABA and GLU before, during and after the TTX-mediated blockade of MFB and in sham and
6-OHDA-lesioned rats [28]. Microdialysis was performed using concentric microdialysis probes
(CMA11 with 1 mm PES membrane, outside diameter 0.6 mm, cut-off 35 kDa, Microbiotech) which
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were positioned into the right MTh (1.8 mm posterior to the bregma, 2 mm lateral to the midline and
6.2 mm below the cortical surface).
Probes were then connected to a high precision micro-injection pump (CMA/100, CMA 159
Microdialysis) and infused at a flow rate of 5 µL/min with an artificial cerebrospinal fluid containing
160 (in mM): NaCl 145, KCl 3, MgCl2 1, CaCl2 1.26, buffered at pH 7.4 with 2 mM phosphate buffer.
After stabilization (4 h), consecutive samples were collected every 10 min. In the acute depleted
animals, TTX was infused in the MFB (see above) at the end of the 3rd sample. All samples were
immediately frozen at −80 ◦C until analyzed. At the end of the experiment, rats were sacrificed, and
the correct position of the probe was histologically verified (36).
For the experiments in 6-OHDA and sham-lesioned animals, the microdialysis experiments were
performed 21–29 days after the lesion.
The concentrations of GABA and GLU in the samples were determined by HPLC analysis
following precolumn derivatization with o-phthalaldehyde and resolution through a C18-reverse phase
chromatographic column (Chrompack, Middleburg, The Netherlands) connected to a fluorometric
detector (excitation 350 nm; emission 450 nm). Buffers were prepared as follows: solvent A, 0.1 M
sodium acetate (pH 5.8): methanol, 80:20; solvent B, 0.1 M sodium acetate (pH 5.8): methanol, 20:80;
solvent C, 0.1 M sodium acetate (pH 6.0): methanol, 80:20. Gradient programme: 100% C for 4 min
from the initiation of the programme; 90% A and 10% B in 1 min; isocratic step for 2 min; 78% A and
22% B in 2 min; isocratic step 172 for 6.50 min; 66% A and 34% B in 1.10 min; isocratic step for 1.50 min;
42% A and 58% B in 1.10 min; isocratic step for 3.50 min; flow rate 0.9 mL/min (Waters 600MS gradient
system). Homoserine was used as an internal standard [21].
4.7. Histological and Microscopic Analysis
At the end of the experiment, the positions of the electrodes (Figure 1b,c) were histologically
checked, and the unilateral dopaminergic lesion in each PD rat was confirmed by quantification of
tyrosine hydroxylase (TH) immunoreactivity, as described and analyzed in our previous publication [28].
4.8. Statistical Analysis
Concerning the single-unit data, statistical comparisons of firing rates and burst parameters (control
vs. 6-OHDA and post-TTX) were conducted using the Kruskal–Wallis test with the Man–Whitney test
for post hoc comparisons (asymptotic significance (2-tailed) p-value).
The firing rate comparison was performed taking into account the mean of the first 5 min of
recording. The comparison of the burst activity was performed in selected 100-s increments in the
presence of stable cortical urethane-induced SWA with a frequency below 3 Hz, as shown elsewhere
(45.) SWA is not affected by DA denervation and DAergic treatment [45].
To investigate the correlation between cortex and MTh, we performed the phase correlation
analysis, with the calculation of descriptive circular statistics being performed using the CircStat
toolbox for MATLAB (2). For the burst analysis, the phase correlation analysis was performed in
the same selected 100 s in the presence of stable cortical SWA. For circular analyses and statistical
comparisons, we included all neurons from the previous analyses.
For each neuron, the linear phase histograms were analyzed, taking into account the up phase of
the SWA, and the spike phase values were used for circular analysis. Then, each neuron was tested for
significant SWA phase-locked firing (comparison of degree; Rayleigh’s uniformity test). The selected
neurons were then used for the analysis of the preferred phase angle, i.e., the mean resultant vector in
degree (with 90◦ corresponding to the peak of the SWA phase), and the vector length (corresponding
to the level of dispersion of the firing). The mean resultant vector length of the phase distribution,
bound between zero and one, was used to quantify the level of phase-locking around the mean angle
(the closer to one, the more grouped the firing; 2).
The differences between the mean of the resultant vector (degree) and the vector lengths of the
three groups (Control, TTX and 6-OHDA) of MTh were tested using the Kruskal-Wallis test.
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All circular analyses were performed using the degree and the upper peak in SWA oscillations
corresponding to a 90◦ phase and the down peak to a 270◦ phase.
In all experimental conditions, all neurons were tested for significantly phase-locked firing; i.e.,
not randomly distributed in relation to the SWA (comparison of degree; Rayleigh’s uniformity test)
according to the method described by Nakamura and colleagues [2]. Firstly, we analyzed the activity
by using the CircStat toolbox for MATLAB. As reported in the text, for each neuron, the linear phase
histograms were analyzed, taking into account the up phase of the SWA, and the spike phase values
were used for circular analysis. Then, each neuron was tested for significant SWA phase-locked firing;
i.e., not-randomly distributed in relation to the SWA (comparison of degree; Rayleigh’s uniformity
test). To exclude this hypothesis, we performed chi-square tests on the percentage of discarded MTh
neurons in the three conditions; i.e., control, acute and chronic DA depletion states. The significance
threshold was set at p < 0.05 for all analyses.
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